Axovant Sciences Ltd. — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Axovant Sciences Ltd. appears in 7 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials7

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

7 shown

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior DisorderNCT02871427 · lead sponsor · 2016-10-20

Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With DementiaNCT02910102 · lead sponsor · 2016-10-01

12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET ExtensionNCT02586909 · lead sponsor · 2016-04-26

Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)NCT02708186 · lead sponsor · 2016-03-01

Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body DementiaNCT02640729 · lead sponsor · 2015-12-01

Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET StudyNCT02585934 · lead sponsor · 2015-10-01

Long Term Safety and Efficacy Study of ProSavin in Parkinson's DiseaseNCT01856439 · lead sponsor · 2011-05-01

Sponsor roles

lead sponsor7

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.